Cristina L. Abrahams
University of Washington Bothell(US)Sutro Biopharma (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Synthesis and Biological Evaluation, HER2/EGFR in Cancer Research, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Alk1 and Alk5 inhibition by Nrp1 controls vascular sprouting downstream of Notch(2015)168 cited
- → Functional Consequences of Wnt-induced Dishevelled 2 Phosphorylation in Canonical and Noncanonical Wnt Signaling(2013)74 cited
- → Discovery of STRO-002, a Novel Homogeneous ADC Targeting Folate Receptor Alpha, for the Treatment of Ovarian and Endometrial Cancers(2022)57 cited
- → Targeting CD74 in multiple myeloma with the novel, site-specific antibody-drug conjugate STRO-001(2018)52 cited
- → Targeting FOLR1 in high-risk CBF2AT3-GLIS2 pediatric AML with STRO-002 FOLR1–antibody-drug conjugate(2022)19 cited
- → Preclinical studies targeting CD74 with STRO-001 antibody-drug conjugate in acute leukemia(2023)15 cited
- → Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001(2023)13 cited
- → Abstract 1782: Discovery and activity of STRO-002, a novel ADC targeting folate receptor alpha for ovarian and endometrial cancer(2018)11 cited
- → Targeting CD74 with Novel Antibody Drug Conjugates (ADCs) for the Treatment of B-Cell Non-Hodgkin's Lymphoma (NHL)(2016)10 cited
- → Abstract NT-090: PRECLINICAL ACTIVITY AND SAFETY OF STRO-002, A NOVEL ADC TARGETING FOLATE RECEPTOR ALPHA FOR OVARIAN AND ENDOMETRIAL CANCER(2019)9 cited